Search Results - "Mahadevia, Parthiv"

Refine Results
  1. 1

    Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review by Burnett, Heather, Emich, Helena, Carroll, Chris, Stapleton, Naomi, Mahadevia, Parthiv, Li, Tracy

    Published in PloS one (08-03-2021)
    “…The burden of epidermal growth factor receptor (EGFR) exon 20 insertion mutation (Exon 20ins) in non-small cell lung cancer is not well understood. A…”
    Get full text
    Journal Article
  2. 2

    Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children by DiFranza, Joseph R, Masaquel, Anthony, Barrett, Amy M, Colosia, Ann D, Mahadevia, Parthiv J

    Published in BMC pediatrics (21-06-2012)
    “…The role of environmental tobacco smoke (ETS) exposure as a risk factor for serious respiratory syncytial virus (RSV) disease among infants and young children…”
    Get full text
    Journal Article
  3. 3

    Persistence of Morbidity and Cost Differences Between Late-Preterm and Term Infants During the First Year of Life by McLaurin, Kimmie K, Hall, Caroline B, Jackson, E. Anne, Owens, Oksana V, Mahadevia, Parthiv J

    Published in Pediatrics (Evanston) (01-02-2009)
    “…Late-preterm infants are known to have greater morbidity and costs compared with term infants during the neonatal period, but less is known about whether these…”
    Get full text
    Journal Article
  4. 4

    Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review by Colosia, Ann D, Masaquel, Anthony, Hall, Caroline Breese, Barrett, Amy M, Mahadevia, Parthiv J, Yogev, Ram

    Published in BMC infectious diseases (20-04-2012)
    “…The objective of this literature review was to determine whether crowding in the home is associated with an increased risk of severe respiratory syncytial…”
    Get full text
    Journal Article
  5. 5

    Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children by Welliver, Robert C., Checchia, Paul A., Bauman, Jay H., Fernandes, Ancilla W., Mahadevia, Parthiv J., Hall, Caroline B.

    Published in Current medical research and opinion (01-09-2010)
    “…Abstract Objective: To review the fatalities among children hospitalized with respiratory syncytial virus (RSV) infection, and identify factors leading to a…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis by Krilov, Leonard R, Masaquel, Anthony S, Weiner, Leonard B, Smith, David M, Wade, Sally W, Mahadevia, Parthiv J

    Published in BMC pediatrics (13-10-2014)
    “…Infection with respiratory syncytial virus (RSV) is common among young children insured through Medicaid in the United States. Complete and timely dosing with…”
    Get full text
    Journal Article
  9. 9

    Lung Cancer Screening With Helical Computed Tomography in Older Adult Smokers: A Decision and Cost-effectiveness Analysis by Mahadevia, Parthiv J, Fleisher, Lee A, Frick, Kevin D, Eng, John, Goodman, Steven N, Powe, Neil R

    “…CONTEXT: Encouraged by direct-to-consumer marketing, smokers and their physicians are contemplating lung cancer screening with a promising but unproven imaging…”
    Get full text
    Journal Article
  10. 10

    Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease by Mehta, Jyotsna, Walsh, Edward E, Mahadevia, Parthiv J, Falsey, Ann R

    Published in Chronic obstructive pulmonary disease (01-06-2013)
    “…Respiratory syncytial virus (RSV), although not typically considered an important pathogen in adults, may cause acute exacerbation of chronic obstructive…”
    Get more information
    Journal Article
  11. 11

    Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study by Palmer, Liisa A, Rousculp, Matthew D, Johnston, Stephen S, Mahadevia, Parthiv J, Nichol, Kristin L

    Published in Vaccine (12-07-2010)
    “…Abstract Acute respiratory illnesses (ARI), comprising influenza-like illness (ILI) and other wintertime respiratory illnesses (ORI), impose substantial health…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective by Mahadevia, Parthiv J, Masaquel, Anthony S, Polak, Mark J, Weiner, Leonard B

    Published in Journal of medical economics (01-10-2012)
    “…The cost-effectiveness of palivizumab has previously been reported among certain guideline-eligible, high-risk premature infants in Medicaid. Because guideline…”
    Get more information
    Journal Article
  14. 14

    Symptom burden among patients with renal cell carcinoma (RCC): content for a symptom index by Harding, Gale, Cella, David, Robinson, Jr, Don, Mahadevia, Parthiv J, Clark, Jason, Revicki, Dennis A

    Published in Health and quality of life outcomes (14-06-2007)
    “…Renal cell carcinoma (RCC) has multiple symptoms stemming from disease and treatments. There are few validated scales for evaluating RCC symptoms. A national…”
    Get full text
    Journal Article
  15. 15

    Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States by Luce, Bryan R, Nichol, Kristin L, Belshe, Robert B, Frick, Kevin D, Li, Su Xia, Boscoe, Audra, Rousculp, Matthew D, Mahadevia, Parthiv J

    Published in Vaccine (02-06-2008)
    “…Abstract Background The US Advisory Committee on Immunization Practices (ACIP) recently expanded the influenza vaccine recommendation to include children 24–59…”
    Get full text
    Journal Article
  16. 16

    Cost-effectiveness analysis of palivizumab among pre-term infant populations covered by Medicaid in the United States by Weiner, Leonard B, Masaquel, Anthony S, Polak, Mark J, Mahadevia, Parthiv J

    Published in Journal of medical economics (01-10-2012)
    “…Medicaid infants are at high risk of severe respiratory syncytial virus (RSV) disease. The study objective was to estimate the cost-effectiveness of…”
    Get more information
    Journal Article
  17. 17

    A survey of children's preferences for influenza vaccine attributes by Flood, Emuella M, Ryan, Kellie J, Rousculp, Matthew D, Beusterien, Kathleen M, Block, Stan L, Hall, Matthew C, Mahadevia, Parthiv J

    Published in Vaccine (10-06-2011)
    “…Abstract Background While annual influenza vaccination is recommended by the CDC for children 6 months and older, vaccination rates remain suboptimal. For…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Healthcare costs within a year of respiratory syncytial virus among medicaid infants by Palmer, Liisa, Hall, Caroline B., Katkin, Julie P., Shi, Nianwen, Masaquel, Anthony S., McLaurin, Kimmie K., Mahadevia, Parthiv J.

    Published in Pediatric pulmonology (01-08-2010)
    “…Limited research exists on the economic impact of respiratory syncytial virus lower respiratory infection (RSV LRI) among vulnerable infant populations. This…”
    Get full text
    Journal Article
  20. 20

    Evaluating the Content Validity, Clarity, and Relevance of Two Patient-Reported Outcomes for Use With Adults With EGFR-Mutated NSCLC by Horn, Marcia K., Liu, Kevin, Mathias, Susan D., Colwell, Hilary H., Li, Tracy, Mahadevia, Parthiv, Pierson, Renee F.

    Published in JTO clinical and research reports (01-08-2021)
    “…NSCLCs account for most lung cancers; approximately 30% involve a mutation in the EGFR gene. This study sought to identify one or more patient-reported outcome…”
    Get full text
    Journal Article